Boosted By Out-Of-State Dark Money, Virginia Passes Dems’ Deceptive Gerrymandering Scheme
Source: The Federalist · Bias: Far Right
Summary
Democrats moved one step closer to disenfranchising millions of rural Virginians on Tuesday night — and for that, they have tens of millions of dollars in out-of-state dark money to thank. According to The New York Times, preliminary results show the constitutional amendment that grants the Democrat-run General Assembly the power to redraw the state’s […]
Related Coverage
- 'Demon in human skin!' Fox News host loses it as Dem threatens to upend Texas Senate race (Far Left — Raw Story)
- Happy Freedom 250! Acting DNI Bill Pulte Fires More “Deep State” Intel Officials (Far Right — The Gateway Pundit)
- Penn Dems boot GOP Rep from House floor for patriotic suit despite encouraging ‘Pride’ attire (Far Right — BizPac Review)
- ‘A total disappointment’: revelers face unbearable heat at Great American State Fair (Center Left — US news | The Guardian)
- Extreme heat temporarily closes Great American State Fair (Center — NewsNation)
- Americans Cheer as B-2 Stealth Bomber, Fighter Aircraft Fly Over Great American State Fair in DC Amid 250 Celebrations (VIDEO) (Far Right — The Gateway Pundit)
- Lawfare: Kangaroo court picks fight with state’s conservative attorney general (Far Right — WorldNetDaily)
- Unnerved ex-officials uncork stark analogy as Trump spy chief cleans house on 'deep state' (Far Left — Raw Story)
Daily Analysis
Read the full Parallax Pulse for April 22, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.
More Headlines From April 22, 2026
- Todd Blanche orders federal reclassification of medical marijuana as less dangerous (Center Right)
- Live updates: Iran fires on container ship in Strait of Hormuz (Center)
- Iran releases video purporting to show commandos seizing ships in Strait of Hormuz (Right)
- The SPLC indictment rewrites the history of the Trump era (Center Right)
- Medical Marijuana Rescheduling Is Legally Puzzling but a 'Huge Win' for Patients, Suppliers, and Scientists (Center Right)








